Justin Skoble | Vice President of Technical Operations
Caribou Biosciences

Justin Skoble, Vice President of Technical Operations, Caribou Biosciences

Justin is the Vice President of Technical Operations at Caribou Biosciences which is a leading clinical-stage CRISPR genome-editing biopharmaceutical company advancing a pipeline of off-the-shelf CAR-T therapies for the treatment of patients with hematologic malignancies. He is responsible for developing, manufacturing, testing, and distributing the company’s critical raw materials and investigational products. Justin has over 20 years of development experience in the biotechnology sector with a focus on immuno-oncology including leadership roles at Actym Therapeutics, Aduro Biotech, Anza Therapeutics, and Cerus Corporation.  Justin earned his undergraduate degree in Biology from Vassar College, his Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and did his post-doctoral fellowship at the University of California, San Francisco.

Appearances:



Advanced Therapies USA 2026 - Day 1 @ 11:10

Designing for Scale: Manufacturing Robust Allogeneic CAR-T Cell Therapies in Hematologic Malignancies

Advanced Therapies USA 2026 - Day 1 @ 17:10

Panel Discussion: Harnessing Technological Innovation to Optimise Supply Chain and Logistics in Advanced Therapies

last published: 05/Mar/26 10:05 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+02034332221